1
|
Parv F, Tudoran C, Parv C, Tudoran M, Ivan V, Pop GN, Maris M, Ungureanu AM, Gadalean F. Ethiological, Clinical and Therapeutic Prognostic Factors for the Evolution of Deep Vein Thrombosis Followed-Up by Serial Venous Doppler Ultrasound. Intern Med J 2022; 53:409-415. [PMID: 35050533 DOI: 10.1111/imj.15693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2021] [Revised: 12/01/2021] [Accepted: 01/10/2022] [Indexed: 11/27/2022]
Abstract
BACKGROUND Deep vein thrombosis (DVT) is a dynamic process that can be followed-up by Doppler ultrasound (DUS). AIMS We aim to evaluate the role of certain factors that can influence the evolution of DVT. METHODS In 121 DVT patients (58.19±14.47 years), 30 with no venous-thromboembolism (VTE) identifiable risk factors, 31 with weak risk factors, 30 with moderate and 30 with strong risk factors, DUS was performed at admission and after 1, 3, 6, 12 and 24 months (M). Favourable evolution was defined as complete thrombus resolution, and unfavourable evolution as incomplete resolution, thrombosis recurrence, and postthrombotic syndrome. RESULTS Complete thrombus resolution was found at M1 in 24.8% of patients, at M6 in 49.6% patients, and at M24 in 61.2% patients. Favourable evolution presented younger patients at M1 and M3 (p = 0.004, p = 0.045), and in cases with earlier treatment (p<0.0001). In proximal DVT the risk of non-favourable evolution was higher (4.05 times at M3, 4.23 times at M6, 4.29 times at M12). Patients with moderate risk factors had an earlier favourable evolution (40% at M1, 56.67% at M6, 70% at M24), and patients with strong risk factors had the slowest rate of thrombus regression (20% at M1, 36.67% at M6, 43.33% at M24). CONCLUSIONS DVT evolution can last up to 24 months. Older age, strong VTE risk factors, proximal DVT localization and late-start of therapy provide unfavourable evolutive prognosis. These cases needs more closely clinical and DUS monitoring to prevent complications. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Florina Parv
- Dept.of Internal Medicine II, Division of Cardiology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania, Eftimie Murgu Sq. no. 2, 300041 Timisoara, RO; County Emergency Hospital Timisoara, Romania.,Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041, Timisoara, Romania
| | - Cristina Tudoran
- Dept.of Internal Medicine II, Division of Cardiology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania, Eftimie Murgu Sq. no. 2, 300041 Timisoara, RO; County Emergency Hospital Timisoara, Romania.,Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041, Timisoara, Romania
| | - Cristina Parv
- Dept. of Functional Sciences, Centre for Modelling Biological Systems and Data Analysis, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041, Timisoara, Romania
| | - Mariana Tudoran
- Dept.of Internal Medicine II, Division of Cardiology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania, Eftimie Murgu Sq. no. 2, 300041 Timisoara, RO; County Emergency Hospital Timisoara, Romania.,Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041, Timisoara, Romania
| | - Viviana Ivan
- Dept.of Internal Medicine II, Division of Cardiology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania, Eftimie Murgu Sq. no. 2, 300041 Timisoara, RO; County Emergency Hospital Timisoara, Romania.,Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041, Timisoara, Romania
| | - Gheorghe Nicusor Pop
- Dept. of Functional Sciences, Centre for Modelling Biological Systems and Data Analysis, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041, Timisoara, Romania
| | - Mihaela Maris
- Dept. of Functional Sciences, Division of Physiopathology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041 Timisoara, RO; County Emergency Hospital Timisoara, Romania
| | - Ana-Maria Ungureanu
- Dept. of Radiology and Medical Imagistics, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041 Timisoara, RO; County Emergency Hospital Timisoara, RO
| | - Florica Gadalean
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041, Timisoara, Romania.,Dept.of Internal Medicine II, Division of Nephrology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania Eftimie Murgu Sq. no. 2, 300041 Timisoara, RO; County Emergency Hospital Timisoara, RO
| |
Collapse
|